Priliximab

Embed this Topic
Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licencing. The patent belongs to the biotechnology company Centocor.
Read article at Wikipedia

Facts from the Community

From the BioVenturist base

Technology involved:

top ↑

We can tell you that Priliximab is a…

If you know more about Priliximab, you can add more facts here »

Similar topics in Freebase

  • Lexitumumab

  • Atlizumab

    Atlizumab is a humanized monoclonal antibody which is used as an immunosuppressive drug.

  • Libivirumab

    Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.

  • Motavizumab

    Motavizumab (proposed INN, trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection in high-risk infants. As of September 2009, it is undergoing Phase II and III...

  • Ertumaxomab

    Ertumaxomab (trade name Rexomun) is a rat-murine hybrid monoclonal antibody designed to treat some types of cancer. As of September 2009, a Phase II clinical trial evaluating the treatment of breast cancer is recruiting participants. It works by linking T-lymphocytes and macrophages to the cancer...

  • Regavirumab

    Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Priliximab was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution